Moving Toward Better Tests and Treatments for Lyme Disease
June 30, 2026
New study finds biomarkers that may someday help clinicians better detect—and possibly cure—early and persistent Borrelia burgdorferi infections
New study finds biomarkers that may someday help clinicians better detect—and possibly cure—early and persistent Borrelia burgdorferi infections
Sensitive test looking for key genetic mutation detects high-risk patients missed by standard testing
Aurenar announced today that it received FDA breakthrough device designation for its V-Link noninvasive neuromodulation system.
Novocure (Nasdaq:NVCR) announced today that its Optune Pax device for treating pancreatic cancer received CE mark approval.
StarMed announced today that it received FDA 510(k) clearance for its platform that delivers radiofrequency (RF) ablation of thyroid nodules.